| 1 |
Clinicopathological Predictors of Recurrence in High-Risk Basal Cell Carcinoma Patients, A Retrospective Analysis |
2026 |
| 2 |
Diagnostic potential of serum humanin in breast cancer among the Egyptian population |
2026 |
| 3 |
Platinum-based vs non-platinum based chemotherapy in metastatic triple negative breast cancer : A retrospective study |
2026 |
| 4 |
The prognostic role of serum human epidermal growth factor receptor (HER2) in metastatic breast cancer patients |
2026 |
| 5 |
Evaluation of the relationship between H. Pylori-infected gastric mucosa and prognosis of gastrointestinal stromal tumor |
2025 |
| 6 |
Gefitinib in Non-Small Cell Lung Cancer: A Prospective Study at South Egypt Cancer Institute |
2025 |
| 7 |
Klotho and LRP6 as Emerging Biomarkers in Gastric Adenocarcinoma: Expression Patterns and Clinical Relevance |
2025 |
| 8 |
Non-Metastatic Triple Negative Breast Cancer with Neuroendocrine Differentiation: Survival Parameters |
2025 |
| 9 |
Predictive and Prognostic Significance of Serum Neuron Specific Enolase in Patients with Metastatic Non-Small Cell Lung Cancer Receiving Gefitinib: A Prospective Study from South Egypt Cancer Institute |
2025 |
| 10 |
Predictive Factors for Site of Local and Systemic Recurrence in Breast Cancer Patients |
2025 |
